gastroparesis glp 1 agonist Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review Frontiers | GLP-1 Receptor Agonists:
Description
Glucagon-like-peptide-1 receptor agonists (GLP-1s) have transformed weight management and treatment of chronic disease
(ii) compound 2 and GLP-1
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors.
These findings align with prior randomized trials and meta-analyses suggesting class-level cardiovascular benefit
